Abstract:Gastric cancer is one of the most lethal malignancies worldwide and is associated with a poor prognosis. Ferroptosis, a form of cell death dependent on iron, has become a research hotspot in recent years due to its role in the development and progression of gastric cancer. Additionally, vasculogenic mimicry (VM), a tumor-associated blood supply mechanism that functions independently of endothelial cells or traditional angiogenesis, has been proven to significantly impact the prognosis and treatment outcomes of gastric cancer. Therefore, exploring the relationship between ferroptosis and VM may help identify new diagnostic biomarkers and therapeutic targets for gastric cancer, thereby improving patient survival rates. This review is the first to systematically summarize the bidirectional regulatory mechanisms between ferroptosis and VM in gastric cancer, and to propose potential strategies for targeted combination therapy.